Avillion appoints Jarrod Longcor as chief business officer

UK-based Avillion LLP, a co-developer of late-stage pharmaceutical assets, has named Jarrod Longcor as Chief Business Officer.

Mr Longcor (pictured) will be responsible for structuring, negotiating and executing successful strategic alliances, co-development agreements, and financial investments, as well as providing management and strategic leadership to the organization. Mr Longcor brings to Avillion LLP over 18 years of pharmaceutical and biotech experience and was previously the Vice President of Corporate Development for Rib-X Pharmaceuticals (now Melinta Therapeutics).